Peregrine Pharmaceuticals : PPHM

All PPHM Articles

30 Articles

247sam | Sep 25, 2012 at 10:29 AM EDT

Today’s Market Winners and Losers

Stocks are up Tuesday, with the Dow Jones Industrial Average up 0.39%, the Nasdaq up 0.36% and the S&P 500…

Paul Ausick | Sep 24, 2012 at 4:04 PM EDT

24/7 Wall St. Closing Bell — September 24, 2012: Markets Can’t Overcome Tech Weakness (AKS, VECO, ORCL, DRI, VLO, LEN, PSDV, RHT, FDS, NEOG, MTN, PPHM, QCOR, LMLP, GOOG, AAPL, FB)

The three major U.S. stock indexes opened lower this morning following weak economic data from Germany (more coverage here). The…

247sam | Sep 24, 2012 at 11:15 AM EDT

Today’s Market Winners and Losers

Photo by Spencer Platt/Getty ImagesThe stock market is down Monday, with the Dow Jones Industrial Average down 0.13%, the Nasdaq…

Paul Ausick | Sep 24, 2012 at 11:12 AM EDT

Peregrine Pharma Collapses on News of Data Errors

Just over two weeks ago Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) reported a statistically significant improvement in the company’s bavituximab lung-cancer…

Paul Ausick | Sep 10, 2012 at 4:09 PM EDT

24/7 Wall St. Closing Bell — September 10, 2012: Markets Spend Another Day Around the Flat Line (AAPL, ITRI, NRG, CELG, S, PPHM, RFIL, JW-A, COOL, PANW, HSOL, UNFI, GERN, TITN, GMCR, KSW, AMZN)

The three major U.S. stock indexes opened lower this morning after a weekend of mixed news from Asia. China’s trade…

Paul Ausick | Sep 7, 2012 at 4:07 PM EDT

24/7 Wall St. Closing Bell — September 7, 2012: Markets Mostly Flat on Weak Jobs Report (APOL, GMCR, NVDA, WY, PCLN, MFRM, SWHC, CMVT, KR, LULU, PPHM, RFIL, TITN, JW-A, ANR, AAPL, AMZN, GOOG, INTC)

The three major U.S. stock indexes opened mixed this morning following a lower-than-expected increase in non-farm payrolls (more coverage here).…

Jon C. Ogg | Sep 7, 2012 at 1:26 PM EDT

Blast Off For Peregrine Pharma on Lung Cancer Update

Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) is surging on news updating its non-small cell lung cancer trial. The company said that interim…

Jon C. Ogg | Dec 29, 2011 at 9:41 AM EST

More Hepatitis C Developments Driving Home (PPHM)

Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) is a year-end winner in small-cap biotech and emerging pharma based upon hepatitis-C Phase II trial…

Douglas A. McIntyre | May 27, 2009 at 1:34 PM EDT

Full 2009 ASCO Cancer & Oncology Primer (ABII, AEZS, ALTH, AMGN, APPA, ARQL, BMY, CLDX, CELG, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, MITI, OGXI, OSIP, PPHM, PFE, ROSG, SNTA, TRBN, ZIOP, ZGEN)

We have compiled an updated lengthy 2009 American Society of Clinical Oncology, or ASCO, document showing many company cancer data…

Douglas A. McIntyre | May 14, 2009 at 4:56 PM EDT

Previewing 2009 ASCO Abstracts (ABII, ALTH, ARQL, CLDX, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, OGXI, OSIP, PPHM, PFE, SNTA, ZIOP)

We are just about to get the first round of abstracts from companies presenting data at this year’s American Society…

Douglas A. McIntyre | Apr 14, 2008 at 12:16 PM EDT

Biotech Busine$$ Daily (ALKS, CADX, CVTX, MNKD, GNBT, PPHM)

Alkermes (NASDAQ: ALKS) and Johnson & Johnson Pharmaceutical Research and Developed today submitted paperwork seeking approval of their partnership drug,…

Douglas A. McIntyre | Dec 17, 2007 at 4:08 PM EST

The 52-Week Low Club

Bearingpoint (BE) Still dropping after loss earlier in the month. Down to $2.53 from 52-week $8.56. General Growth Properties (GGP)…

Douglas A. McIntyre | Nov 15, 2007 at 4:38 PM EST

The 52-Week Low Club

Novastar Finl Inc (NFI) Poor earnings and possible delisting. Drops to $1.72 from 52-week high of $127.20. Standard Pacific (SPF)…

Douglas A. McIntyre | Sep 18, 2007 at 5:03 AM EDT

The Nasdaq: Where Delisting Means Nothing

Dell (DELL) got another delisting warning yesterday. It has to file its financials on time, or risk being thrown off…

Douglas A. McIntyre | Jun 29, 2007 at 3:17 PM EDT

Blackstone (BX) Leads The 52-Week Low Club

Blackstone (BX) Investors still worry about slowing private equity and tax issues. Shares fall to $28.75 from post-IPO high of…

1 2

Peregrine Pharmaceuticals : PPHM

All PPHM Articles

Today’s Market Winners and Losers

24/7 Wall St. Closing Bell — September 24, 2012: Markets Can’t Overcome Tech Weakness (AKS, VECO, ORCL, DRI, VLO, LEN, PSDV, RHT, FDS, NEOG, MTN, PPHM, QCOR, LMLP, GOOG, AAPL, FB)

Today’s Market Winners and Losers

Peregrine Pharma Collapses on News of Data Errors

24/7 Wall St. Closing Bell — September 10, 2012: Markets Spend Another Day Around the Flat Line (AAPL, ITRI, NRG, CELG, S, PPHM, RFIL, JW-A, COOL, PANW, HSOL, UNFI, GERN, TITN, GMCR, KSW, AMZN)

24/7 Wall St. Closing Bell — September 7, 2012: Markets Mostly Flat on Weak Jobs Report (APOL, GMCR, NVDA, WY, PCLN, MFRM, SWHC, CMVT, KR, LULU, PPHM, RFIL, TITN, JW-A, ANR, AAPL, AMZN, GOOG, INTC)

Blast Off For Peregrine Pharma on Lung Cancer Update

More Hepatitis C Developments Driving Home (PPHM)

Full 2009 ASCO Cancer & Oncology Primer (ABII, AEZS, ALTH, AMGN, APPA, ARQL, BMY, CLDX, CELG, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, MITI, OGXI, OSIP, PPHM, PFE, ROSG, SNTA, TRBN, ZIOP, ZGEN)

Previewing 2009 ASCO Abstracts (ABII, ALTH, ARQL, CLDX, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, OGXI, OSIP, PPHM, PFE, SNTA, ZIOP)

Biotech Busine$$ Daily (ALKS, CADX, CVTX, MNKD, GNBT, PPHM)

The 52-Week Low Club

The 52-Week Low Club

The Nasdaq: Where Delisting Means Nothing

Blackstone (BX) Leads The 52-Week Low Club

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

Peregrine Pharmaceuticals : PPHM

All PPHM Articles

Today’s Market Winners and Losers

24/7 Wall St. Closing Bell — September 24, 2012: Markets Can’t Overcome Tech Weakness (AKS, VECO, ORCL, DRI, VLO, LEN, PSDV, RHT, FDS, NEOG, MTN, PPHM, QCOR, LMLP, GOOG, AAPL, FB)

Today’s Market Winners and Losers

Peregrine Pharma Collapses on News of Data Errors

24/7 Wall St. Closing Bell — September 10, 2012: Markets Spend Another Day Around the Flat Line (AAPL, ITRI, NRG, CELG, S, PPHM, RFIL, JW-A, COOL, PANW, HSOL, UNFI, GERN, TITN, GMCR, KSW, AMZN)

24/7 Wall St. Closing Bell — September 7, 2012: Markets Mostly Flat on Weak Jobs Report (APOL, GMCR, NVDA, WY, PCLN, MFRM, SWHC, CMVT, KR, LULU, PPHM, RFIL, TITN, JW-A, ANR, AAPL, AMZN, GOOG, INTC)

Blast Off For Peregrine Pharma on Lung Cancer Update

More Hepatitis C Developments Driving Home (PPHM)

Full 2009 ASCO Cancer & Oncology Primer (ABII, AEZS, ALTH, AMGN, APPA, ARQL, BMY, CLDX, CELG, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, MITI, OGXI, OSIP, PPHM, PFE, ROSG, SNTA, TRBN, ZIOP, ZGEN)

Previewing 2009 ASCO Abstracts (ABII, ALTH, ARQL, CLDX, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, OGXI, OSIP, PPHM, PFE, SNTA, ZIOP)

Biotech Busine$$ Daily (ALKS, CADX, CVTX, MNKD, GNBT, PPHM)

The 52-Week Low Club

The 52-Week Low Club

The Nasdaq: Where Delisting Means Nothing

Blackstone (BX) Leads The 52-Week Low Club

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

Featured Reads

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings